Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
Indian J Dermatol Venereol Leprol
;
2006 Sep-Oct; 72(5): 373-5
Artigo
em Inglês
| IMSEAR
| ID: sea-52622
ABSTRACT
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Pomadas
/
Neoplasias Cutâneas
/
Idoso
/
Humanos
/
Masculino
/
Carcinoma Basocelular
/
Face
/
Aminoquinolinas
Idioma:
Inglês
Revista:
Indian J Dermatol Venereol Leprol
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS